TY - JOUR AU - Ma, Patrick C. PY - 2017 TI - Special issue: “MET as actionable target in cancer therapy” JF - Annals of Translational Medicine; Vol 5, No 1 (January 13, 2017): Annals of Translational Medicine (Focus on “MET as Actionable Target in Cancer Therapy”) Y2 - 2017 KW - N2 - MET (c-Met, or c-MET) receptor is a multifunctional receptor tyrosine kinase that has been known for many years of its pivotal role in human developmental and cancer signaling. The natural ligand for MET is hepatocyte growth factor [HGF; also called scatter factor (SF)], which can act in autocrine, endocrine or paracrine fashion on the MET-expressing epithelial cells (1). UR - https://atm.amegroups.org/article/view/13241